Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Solubility: DMSO: 100 mg/mL(200
CN[C@H]1CN(C[C@@H]1OC)C1=CC=C2C(=N1)N(C=C(C(O)=O)C2=O)C1=NC=CS1
SGK3-PROTAC1 suppresses proliferation of ZR-75-1 and CAMA-1 cancer cell lines treated with a PI3K inhibitor more effectively than could be achieved by a conventional SGK isoform inhibitor
Mycophenolate
BIBF 1120 (esylate) - CAS# 656247-18-6 Size:Solid 10 mg Solubility: DMSO: 100 mg/mL(200Nintedanib, also known as BIBF 1120, is an orally bioavailable inhibitor of vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet derived growth factor receptor (PDGFR). Intedanib selectively binds to and inhibits vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet derived growth factor receptor (PDGFR) tyrosine kinases, which may result in the
US$ 388.50
US$ 188.00
US$ 175.50
US$ 152.00
US$ 433.50
US$ 1320.00
US$ 303.50
US$ 138.50
US$ 805.00
US$ 138.00